Table:
begin	end	state
1	31	cytoplasmic
32	49	transmembrane
50	60	non-cytoplasmic
61	80	transmembrane
81	111	cytoplasmic
112	137	transmembrane
138	166	non-cytoplasmic
167	186	transmembrane
187	197	cytoplasmic
198	216	transmembrane
217	235	non-cytoplasmic
236	264	transmembrane
265	275	cytoplasmic
276	298	transmembrane
299	324	non-cytoplasmic
325	346	transmembrane
347	366	cytoplasmic
367	389	transmembrane
390	408	non-cytoplasmic
409	426	transmembrane
427	446	cytoplasmic
447	467	transmembrane
468	469	non-cytoplasmic

Input:
>GFF3450 FitnessBrowser__psRCH2:GFF3450
MSDKTSLAAGTFAGARARIQDNASRGLWSSRWVFFLAATGSAVGLGNIWKFPYVTGQNGG
GAFVLVYLACILLIGIPLLMTEVMIGRRGRANPDGAVARLAREAGASSRWRVVGWLGGLT
GFLILSFYLVVAGWALAYVPATFSGGFAGVSGEASGELFGALLADPLRLVVCATLVLAAT
MLIVGFGVRGGLERSLRFLMPGLFVLMLVLVVYAAIEGEFAQALQFLFVPDFSALTAQSV
LIALGHAFFTLSLGCGAMMVYGSYLPEGTSIAKTSILVALADTAVALLAGLAIFPLVFGN
GLEPGAGPGLIFVTLPIAFGQMPLGQVVGGLFFIMLVIAALTSAISLSEPSIAWLTERFR
ISRTKAVLGSGLVLWLLSLGSVFSFNHWADYQLFGKTFFDTLDYLTTNWLMPLGGLGTVL
FTGWVLQRQVVSEAIGIRNAGLFQAWWNLLRYGTPVAIVLVFLNLLGLI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server